The role of CTLA-4 in the regulation and initiation of T-cell responses - PubMed (original) (raw)

Review

The role of CTLA-4 in the regulation and initiation of T-cell responses

C A Chambers et al. Immunol Rev. 1996 Oct.

No abstract available

PubMed Disclaimer

Similar articles

• The complexities of T-cell co-stimulation: CD28 and beyond.
  Sperling AI, Bluestone JA. Sperling AI, et al. Immunol Rev. 1996 Oct;153:155-82. doi: 10.1111/j.1600-065x.1996.tb00924.x. Immunol Rev. 1996. PMID: 9010723 Review. No abstract available.
• CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?
  van Gool SW, Barcy S, Devos S, Vandenberghe P, Ceuppens JL, Thielemans K, de Boer M. van Gool SW, et al. Res Immunol. 1995 Mar-Apr;146(3):183-96. doi: 10.1016/0923-2494(96)80256-2. Res Immunol. 1995. PMID: 8525052 Review. No abstract available.
• New protein steals the show as 'costimulator' of T cells.
  Cohen J. Cohen J. Science. 1993 Nov 5;262(5135):844-5. doi: 10.1126/science.7694360. Science. 1993. PMID: 7694360 No abstract available.
• CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation.
  Linsley PS, Ledbetter J, Peach R, Bajorath J. Linsley PS, et al. Res Immunol. 1995 Mar-Apr;146(3):130-40. doi: 10.1016/0923-2494(96)80246-x. Res Immunol. 1995. PMID: 8525042 Review. No abstract available.
• Role of the CD28-B7 costimulatory pathways in T cell-dependent B cell responses.
  Hathcock KS, Hodes RJ. Hathcock KS, et al. Adv Immunol. 1996;62:131-66. doi: 10.1016/s0065-2776(08)60429-0. Adv Immunol. 1996. PMID: 8781268 Review. No abstract available.

Cited by

• mTOR Deletion Alleviates CD4+ T-Cell Dysfunction in Sepsis through Reducing CTLA4 Accumulation Mediated by Rescuing Autophagy.
  Lei X, Zhao G, Xie Y, Cui N. Lei X, et al. Mediators Inflamm. 2024 Jul 25;2024:4233439. doi: 10.1155/2024/4233439. eCollection 2024. Mediators Inflamm. 2024. PMID: 39104632 Free PMC article.
• Differential Response of Mycosis Fungoides Cells to Vorinostat.
  Bordeaux ZA, Reddy SV, Lee K, Lu W, Choi J, Miller M, Roberts C, Pollizzi A, Kwatra SG, Kwatra MM. Bordeaux ZA, et al. Int J Mol Sci. 2023 Apr 29;24(9):8075. doi: 10.3390/ijms24098075. Int J Mol Sci. 2023. PMID: 37175780 Free PMC article.
• Systemic Sclerosis Association with Malignancy.
  Lepri G, Catalano M, Bellando-Randone S, Pillozzi S, Giommoni E, Giorgione R, Botteri C, Matucci-Cerinic M, Antonuzzo L, Guiducci S. Lepri G, et al. Clin Rev Allergy Immunol. 2022 Dec;63(3):398-416. doi: 10.1007/s12016-022-08930-4. Epub 2022 Sep 19. Clin Rev Allergy Immunol. 2022. PMID: 36121543 Free PMC article. Review.
• Understanding the Mechanism of Diabetes Mellitus in a LRBA-Deficient Patient.
  Hawari I, Ericsson J, Kabeer BSA, Chaussabel D, Alsulaiti A, Sharari SA, Maccalli C, Khan FA, Hussain K. Hawari I, et al. Biology (Basel). 2022 Apr 18;11(4):612. doi: 10.3390/biology11040612. Biology (Basel). 2022. PMID: 35453810 Free PMC article.
• Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject 'cold' tumors.
  Semmrich M, Marchand JB, Fend L, Rehn M, Remy C, Holmkvist P, Silvestre N, Svensson C, Kleinpeter P, Deforges J, Junghus F, Cleary KL, Bodén M, Mårtensson L, Foloppe J, Teige I, Quéméneur E, Frendéus B. Semmrich M, et al. J Immunother Cancer. 2022 Jan;10(1):e003488. doi: 10.1136/jitc-2021-003488. J Immunother Cancer. 2022. PMID: 35058324 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • SciCrunch